β-Nicotinamide Mononucleotide (NMN) Crystalline Powder 99% HPLC

Overview

Nicotinamide Mononucleotide (NMN), also known as β-Nicotinamide Mononucleotide, is a naturally occurring nucleotide involved in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is an essential coenzyme participating in numerous cellular biochemical reactions, including energy metabolism and oxidation-reduction processes.

NMN is a precursor in the NAD+ biosynthesis pathway. It can be converted into NAD+ through enzymatic reactions involving nicotinamide mononucleotide adenylyltransferase (NMNAT). Because of its biochemical relationship with NAD+, NMN has become an ingredient of interest in nutritional research and dietary supplement formulation.

Commercial NMN is commonly available as a crystalline powder. The β-form represents the specific molecular configuration used in many commercial NMN ingredient specifications. Product identity, purity, and physical characteristics are important considerations when evaluating NMN raw materials for formulation and quality control.

This product is β-Nicotinamide Mononucleotide Crystalline Powder with a specified purity of 99% by HPLC. HPLC purity testing provides an analytical reference for evaluating the proportion of the target NMN compound in the tested sample. It is important to distinguish HPLC purity from overall ingredient content or assay results obtained through different analytical methods.

NMN crystalline powder can be considered for dietary supplement development, functional food formulations, and nutritional ingredient blends. Its application suitability depends on the formulation design, ingredient compatibility, processing conditions, and regulatory requirements of the intended market.

Technical Specifications

Note: The 99% HPLC purity is the specified product parameter. Individual test limits, physical characteristics, and analytical acceptance criteria should be confirmed through the applicable product specification and batch-specific COA.

Functional and Formulation Characteristics

NMN has several biochemical and physicochemical characteristics relevant to ingredient evaluation and nutritional formulation.

1. Role in NAD+ Biosynthesis

NMN is an intermediate in the NAD+ biosynthesis pathway. It participates in the metabolic process through which cells produce NAD+, a coenzyme involved in cellular energy metabolism, mitochondrial function, and various enzyme-mediated reactions.

This biochemical role provides the scientific background for NMN as a nutritional research ingredient. However, the biochemical function of NAD+ does not independently establish the clinical efficacy of NMN supplementation or specific health outcomes.

2. Crystalline Powder Form

The crystalline powder format provides a solid ingredient suitable for controlled weighing, blending, and incorporation into different formulation systems. Physical properties such as particle size, bulk density, moisture content, and crystal characteristics can influence material handling and manufacturing performance.

For powder-based products, these characteristics should be evaluated during formulation development to support consistent blending and processing.

3. HPLC Purity Standardization

A 99% HPLC specification provides a defined analytical purity target for NMN raw material. High-performance liquid chromatography is used to separate and evaluate chemical components within a sample.

HPLC purity is an important quality parameter, but it should be interpreted together with compound identification, assay methodology, water content, and other relevant analytical results. The analytical method and calculation basis should be documented in the product specification.

4. Compatibility with Supplement Ingredients

NMN can be considered for formulations containing other nutritional ingredients, depending on their chemical compatibility and processing requirements. Formulators may evaluate its inclusion in blends containing vitamins, minerals, amino acids, and other nutritional compounds.

Compatibility testing should consider moisture exposure, pH conditions, temperature, light sensitivity, and storage stability. These factors may affect the quality of the finished formulation.

Application Context

NMN crystalline powder is primarily considered for nutritional and supplement-related product development.

Dietary Supplements

Dietary supplements represent an important formulation category for NMN. The crystalline powder can be used as an active ingredient in products developed in capsule, tablet, or powder formats. The required ingredient quantity depends on the intended serving size, formulation specifications, and applicable regulatory requirements.

Functional Foods

NMN may be evaluated for selected functional food applications where the ingredient is permitted. Formulation development should consider food matrix compatibility, processing temperatures, moisture exposure, and product stability.

The suitability of NMN for beverages and other food systems requires specific solubility and stability assessments.

Nutritional Formulations

NMN can be incorporated into multi-ingredient nutritional formulations. These products may combine different vitamins, minerals, and other nutritional compounds. Ingredient interactions and finished-product uniformity should be evaluated during development.

Capsules and Tablets

The crystalline powder format can be considered for capsule filling and tablet manufacturing. Processing characteristics, including flowability, compressibility, particle size, and compatibility with excipients, should be assessed before commercial production.

Powder Blends

NMN may be included in selected powder blends and nutritional mixtures. Uniform distribution is an important consideration, particularly when the ingredient is incorporated at relatively low inclusion levels. Blending procedures and particle-size compatibility can influence batch consistency.

Oral Liquid and Drops

Oral liquid formulations and drops represent potential development formats. However, NMN suitability in these systems should not be assumed from its powder specifications alone. Solubility, pH compatibility, degradation behavior, preservative compatibility, and storage stability require formulation-specific evaluation.

Composition and Standardization

β-Nicotinamide Mononucleotide is a nucleotide compound composed of a nicotinamide group, ribose sugar, and phosphate group. Its chemical structure distinguishes it from related compounds such as nicotinamide riboside (NR) and nicotinamide (NAM).

For commercial ingredient evaluation, chemical identity and purity are two important standardization parameters. The specified 99% HPLC purity provides a reference for assessing the target NMN component in the sample.

HPLC analysis is commonly used to evaluate chromatographic purity and quantify the target compound according to a defined analytical procedure. The reference standard, chromatographic conditions, sample preparation, and calculation method should be documented to support reproducibility.

Additional quality control parameters include heavy metals, microbiological indicators, residual solvents, and moisture-related measurements. Heavy metals testing may cover lead (Pb), arsenic (As), mercury (Hg), and cadmium (Cd). Microbiological testing may include total plate count, yeast and mold, Escherichia coli, and Salmonella, according to applicable specifications.

Residual solvent analysis can be conducted using gas chromatography (GC), including testing for ethanol where relevant to the manufacturing process. Loss on drying or water content testing provides additional information about the moisture-related characteristics of the crystalline material.

A batch-specific Certificate of Analysis (COA) is an important document for reviewing analytical results and confirming compliance with established product specifications. For ingredient qualification, the COA should be evaluated together with the technical specification, analytical methods, and applicable regulatory requirements.